ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Compartment-specific PPARδ activity controls the outcome of cancer–immune cell competition and immunotherapy efficacy

Study limitation reported by the research below: “The constitutively active VP16/VP64-PPARδ fusion used in genetic models does not equivalently replicate pharmacological PPARδ activation, limiting direct translation of genetic findings to drug use.”

Papers